Crossmark

GOT1 promotes endometrial cancer progression by regulating ferroptosis through the STAT3-GPX4 axis and attenuating medroxyprogesterone acetate sensitivity

Crossref DOI link: https://doi.org/10.1038/s41417-026-01044-5

Published Online: 2026-06-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Yiran

Shen, Yuting

Lu, Wen https://orcid.org/0009-0006-5558-2820
License Information

Text and Data Mining valid from 2026-06-02

Version of Record valid from 2026-06-02
More Information

Article History

Received: 21 October 2025

Revised: 10 March 2026

Accepted: 26 May 2026

First Online: 2 June 2026

Competing interests

: The authors declare no competing interests.

: This study was approved by the Ethics Committee of Hefei Comprehensive National Science Center for Health and Medicine (approval number: IHM-API-2025-113) and the Medical Ethics Committee of Shanghai First Maternity and Infant Health Hospital (approval number: KS25340). All procedures involving human participants and animals were conducted in accordance with relevant ethical guidelines and regulations.

: Informed consent was obtained from all subjects.

Document is current

Any future updates will be listed below